A total of 270 patients with diverse advanced cancers consisting of 90 patients with PIK3CA mutations and 180 controls with wt PIK3CA (matched by tumor type, gender, and age) were analyzed and their clinical and pathologic characteristics are listed in Table 1. This evidence concerns the gene PIK3CA and neoplasm.